Management of advanced heart failure

Clinical Cornerstone - Tập 4 - Trang 42-52 - 2002
Adrian B. Van Bakel1
1Associate Professor of Medicine Charleston, South Carolina, USA

Tài liệu tham khảo

Pitt, 2000, Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study. ELITE 11, Lancet, 355, 1582, 10.1016/S0140-6736(00)02213-3 Packer, 1999, Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group, Circulation, 100, 2312, 10.1161/01.CIR.100.23.2312 Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. RADIANCE Study, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101 1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 Connors, 1996, The effectiveness of right heart catheterization in the initial care of critically ill patients, JAMA, 276, 889, 10.1001/jama.1996.03540110043030 Gheorghiade, 2000, Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation of Chronic Heart Failure (OPTIME-CHF) Singh, 1995, Amiodarone in patients with congestive heart failure in asymptomatic ventricular arrhythmias. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure, N Engl J Med, 333, 77, 10.1056/NEJM199507133330201